UnitedHealth price target lowered to $584 from $618 at Morgan Stanley

Morgan Stanley lowered the firm’s price target on UnitedHealth to $584 from $618 and keeps an Overweight rating on the shares. Into the print, the firm expects more questions than answers, with Morgan Stanley saying cost trend concerns and reduced transparency as a result of the Change Healthcare cyberattack drive likely upward pressure on medial loss ratios, the analyst tells investors in a research note.